PSNL Competitors & Alternatives
Compare Personalis Inc with similar stocks in the same industry
Diagnostics & Research
PSNL
Main Stock$15.04
Tradestie Score
57
Market Cap
$612.76M
Revenue Growth
-0.2%
Analyst Upside
-24.0%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$71.80
|
$2.24B | - | 62 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.02
|
$2.22B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$90.35
|
$1.77B | - | 52 | Compare |
|
NEOG
Neogen Corp
|
$9.65
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.23
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$14.11
|
$1.13B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$28.76
|
$798.40M | - | 61 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.42
|
$719.31M | - | 58 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.86
|
$719.23M | - | 59 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$22.98
|
$667.77M | - | 57 | Compare |
More PSNL Analysis
Data updated: Jul 14, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry